Pandemic Timeline

Tag: gene sequence

UNC Chapel Hill files patent US7279327: Methods for producing recombinant coronavirus

A helper cell for producing an infectious, replication defective, coronavirus (or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at…

Sequoia Pharmaceuticals files patent US7151163: Antiviral agents for the treatment, control and prevention of infections by coronaviruses

The invention provides compositions and methods that are useful for preventing and treating a coronavirus infection in a subject. More specifically, the invention provides peptides and conjugates and pharmaceutical compositions containing those peptides and conjugates that block fusion of a coronavirus, such as the SARS virus, to a target cell. This blocking mechanism prevents or…

Ablynx files patent US9193780: Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

The present invention relates in part to amino acid sequences that are directed against and/or that can specifically bind to an envelope protein of a virus, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. — Patent US9193780B2…

Reiner Fuellmich Interviews Dr David Martin – CDC Patent Fraud

The interview cited below was conducted as part of the Stiftung Corona Ausschuss project that is expected to result in a “Nuremberg 2” trial.  Reiner Fuellmich is a lawyer for the Stiftung Corona Ausschuss project, and so this could be considered to be a deposition hearing. As Gary D. Barnett said, This recent interview between Dr. David…